Pinterest • The world’s catalogue of ideas

Explore these ideas and much more!

from Foursquare

Penn State Milton S. Hershey Medical Center

Dr. Harold Harvey of Penn St Hershey Medical Center speaks on Adjuvant Endocrine Therapy and the effects of clinical trials. #sabcs13 #JTCCbreast

from Foursquare

John Theurer Cancer Center

The 11th Annual North Jersey San Antonio Breast Cancer Review 2013 is underway! #JTCancerCenter hosted some of the best oncologists and speakers! Our conference room was filled with numerous oncologists and health professionals from all over the country! #SABCS13 #JTCCbreast

from Foursquare

John Theurer Cancer Center

February 28th, 2014 - 11th ANNUAL SAN ANTONIO BREAST CANCER REVIEW 2013 ( #SABCS13 )The #JTCancerCenter hosts some of the best breast oncologists as they recap information from the San Antonio Breast Cancer Review 2013! Our own, Dr. Stanley E. Waintraub, chief of the Breast Oncology division, speaks along several other esteemed MDs from MD Anderson, NYU, The Mayo Clinic, The Albert Einstein MC and Hershey Medical Center! 7:00am - Registration & Continental Breakfast 7:30am -3:30pm…

from Foursquare

UPMC Presbyterian

Dr. Adam Brafsky from the University of Pittsburg Medical Center, speaks on Genomics and Breast Cancer. #SABCS13 #JTCCbreast

from Foursquare

Banner MD Anderson Cancer Center

Dr. Mary Cianfrocca of Banner MD Anderson Cancer Center presents new approaches to metastatic breast cancer treatment and speaks about Neoadjuvant Chemotherapy. #SABCS13 #JTCCbreast

from Foursquare

NYU Langone Medical Center

Dr. Freya Schnabel of NYU Langone Medical discusses advancements in surgical breast techniques. #SABCS13 #JTCCbreast

from Foursquare

Albert Einstein Medical Center

Dr. Lawrence Solin, Chairman of Radiation Oncology at Einstein Health, is introduced by Dr. Stanley Waintraub, Chief of #JTCancerCenter Breast Oncology. #SABCS13 #JTCCbreast

from Foursquare

Edith Sanford Breast Cancer Foundation

Dr. Brian Leyland-Jones of Edith Sanford speaks on newer ways to use Targeted Agents. Says Leylan-Jones, "Adjuvant Paclitaxel and Trastruzumab have shown remarkable results with a 3-year DFS at 98.7%." #jtccbreast #sabcs13